BERKLEY W R CORP - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 46 filers reported holding PHOENIX BIOTECH ACQUISITION in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BERKLEY W R CORP ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2023$512,581
-51.4%
47,199
-51.2%
0.03%
-47.6%
Q2 2023$1,054,869
-0.4%
96,777
-2.4%
0.06%
-6.0%
Q1 2023$1,058,997
-73.0%
99,157
-74.2%
0.07%
-68.4%
Q4 2022$3,915,918
+0.9%
384,6300.0%0.21%
+12.8%
Q3 2022$3,881,000
+30.5%
384,630
+29.6%
0.19%
+27.9%
Q2 2022$2,973,000
+0.1%
296,7300.0%0.15%
-3.3%
Q1 2022$2,969,000
+1.0%
296,7300.0%0.15%
-6.2%
Q4 2021$2,941,000296,7300.16%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q1 2022
NameSharesValueWeighting ↓
Atalaya Capital Management LP 450,000$4,514,0000.53%
Lynwood Capital Management Inc. 34,615$347,0000.39%
Sage Rock Capital Management LP 183,998$1,844,0000.36%
HGC Investment Management Inc. 1,000,000$10,013,0000.31%
MMCAP International Inc. SPC 370,000$3,707,0000.30%
Context Capital Management, LLC 400,000$4,008,0000.29%
Bulldog Investors, LLP 99,064$993,0000.27%
First Trust Capital Management L.P. 352,600$3,533,0000.25%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,029,262$10,323,0000.24%
NEXPOINT ASSET MANAGEMENT, L.P. 217,482$2,181,0000.19%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders